The Blue Cross and Blue Shield company will stop marketing most of its Medicare Advantage policies online beginning May 1.

Elevance, one of the largest health insurers in the U.S., spent 86.4% of its premium revenues on medical expenses.

Argus raised the firm’s price target on Elevance Health (ELV) to $465 from $450 and keeps a Buy rating on the shares. The company’s results ...